170 related articles for article (PubMed ID: 21767176)
1. Plan robustness in proton beam therapy of a childhood brain tumour.
Lassen-Ramshad Y; Vestergaard A; Muren LP; Høyer M; Petersen JB
Acta Oncol; 2011 Aug; 50(6):791-6. PubMed ID: 21767176
[TBL] [Abstract][Full Text] [Related]
2. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking.
Munck Af Rosenschöld P; Engelholm S; Ohlhues L; Law I; Vogelius I; Engelholm SA
Acta Oncol; 2011 Aug; 50(6):777-83. PubMed ID: 21767174
[TBL] [Abstract][Full Text] [Related]
3. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
4. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
Baumert BG; Norton IA; Lomax AJ; Davis JB
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
[TBL] [Abstract][Full Text] [Related]
5. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
6. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours.
Petersen JB; Lassen Y; Hansen AT; Muren LP; Grau C; Høyer M
Acta Oncol; 2011 Aug; 50(6):823-8. PubMed ID: 21767180
[TBL] [Abstract][Full Text] [Related]
7. A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.
Feuvret L; Noel G; Weber DC; Pommier P; Ferrand R; De Marzi L; Dhermain F; Alapetite C; Mammar H; Boisserie G; Habrand JL; Mazeron JJ
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):944-54. PubMed ID: 17889276
[TBL] [Abstract][Full Text] [Related]
8. Proton radiotherapy for liver tumors: dosimetric advantages over photon plans.
Wang X; Krishnan S; Zhang X; Dong L; Briere T; Crane CH; Martel M; Gillin M; Mohan R; Beddar S
Med Dosim; 2008; 33(4):259-67. PubMed ID: 18973852
[TBL] [Abstract][Full Text] [Related]
9. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma.
Arvold ND; Niemierko A; Broussard GP; Adams J; Fullerton B; Loeffler JS; Shih HA
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e495-500. PubMed ID: 22285662
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy.
Fogliata A; Scorsetti M; Navarria P; Catalano M; Clivio A; Cozzi L; Lobefalo F; Nicolini G; Palumbo V; Pellegrini C; Reggiori G; Roggio A; Vanetti E; Alongi F; Pentimalli S; Mancosu P
Acta Oncol; 2013 Apr; 52(3):545-52. PubMed ID: 22671576
[TBL] [Abstract][Full Text] [Related]
12. Novalis intensity-modulated radiosurgery: methods for pretreatment planning.
Jensen RL; Wendland MM; Chern SS; Shrieve DC
Neurosurgery; 2008 May; 62(5 Suppl):A2-9; discussion A9-10. PubMed ID: 18580777
[TBL] [Abstract][Full Text] [Related]
13. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
14. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
15. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
16. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.
Wolff D; Stieler F; Welzel G; Lorenz F; Abo-Madyan Y; Mai S; Herskind C; Polednik M; Steil V; Wenz F; Lohr F
Radiother Oncol; 2009 Nov; 93(2):226-33. PubMed ID: 19765846
[TBL] [Abstract][Full Text] [Related]
17. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma.
Brodin NP; Munck Af Rosenschöld P; Aznar MC; Kiil-Berthelsen A; Vogelius IR; Nilsson P; Lannering B; Björk-Eriksson T
Acta Oncol; 2011 Aug; 50(6):806-16. PubMed ID: 21767178
[TBL] [Abstract][Full Text] [Related]
18. Introducing an on-line adaptive procedure for prostate image guided intensity modulate proton therapy.
Zhang M; Westerly DC; Mackie TR
Phys Med Biol; 2011 Aug; 56(15):4947-65. PubMed ID: 21772078
[TBL] [Abstract][Full Text] [Related]
19. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
Mock U; Bogner J; Georg D; Auberger T; Pötter R
Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
[TBL] [Abstract][Full Text] [Related]
20. Is it necessary to plan with safety margins for actively scanned proton therapy?
Albertini F; Hug EB; Lomax AJ
Phys Med Biol; 2011 Jul; 56(14):4399-413. PubMed ID: 21709340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
